Caption Management »

Krystal Biotech shares owned by Caption Management

Quarter-by-quarter ownership of Krystal Biotech (KRYS) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Krystal Biotech

Tip: Access up to 7 years of quarterly data

All positions including Krystal Biotech held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Krystal Biotech by Caption Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.9M 80k 124.06
2023-09-30 $7.8M 67k 116.00
2023-06-30 $4.7M 40k 117.40
2021-12-31 $4.8M 69k 69.95

More positions owned by Caption Management

Cytokinetics Com New Call Option (CYTK)
Verizon Communications Put Option (VZ)
Metropcs Communications Call Option (TMUS)
Citigroup Com New Put Option (C)
Mondelez Intl Cl A Put Option (MDLZ)
stock Call Option
Spdr Ser Tr S&p Regl Bkg Put Option (KRE)
Kenvue Call Option (KVUE)
Palo Alto Networks Put Option (PANW)
Sarepta Therapeutics Call Option (SRPT)
Spdr Ser Tr S&p Biotech Call Option (XBI)
United States Steel Corporation Call Option (X)
Tal Education Group Sponsored Ads Call Option (TAL)
Zillow Group Cl C Cap Stk Call Option (Z)
Agnico Call Option (AEM)

View all positions for Caption Management

Top funds holding Krystal Biotech

venBio Select Advisor
Vanguard Group
Redmile Group
Frazier Life Sciences Management
Jennison Associates
Lord, Abbett & Co
Dimensional Fund Advisors
Ikarian Capital
Credit Suisse
T. Rowe Price Associates
Balyasny Asset Management
TimesSquare Capital Management
First Turn Management
Goldman Sachs Group
Jpmorgan Chase & Co

View all funds holding Krystal Biotech